{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:52:21Z","timestamp":1792162341317,"version":"4.4.0"},"reference-count":23,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"\n Importance<\/jats:title>\n Fewer than 5% of patients labeled with a penicillin allergy are truly allergic. The standard of care to remove the penicillin allergy label in adults is specialized testing involving prick and intradermal skin testing followed by an oral challenge with penicillin. Skin testing is resource intensive, limits practice to specialist-trained physicians, and restricts the global population who could undergo penicillin allergy delabeling.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To determine whether a direct oral penicillin challenge is noninferior to the standard of care of penicillin skin testing followed by an oral challenge in patients with a low-risk penicillin allergy.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This parallel, 2-arm, noninferiority, open-label, multicenter, international randomized clinical trial occurred in 6 specialized centers, 3 in North America (US and Canada) and 3 in Australia, from June 18, 2021, to December 2, 2022. Eligible adults had a PEN-FAST score lower than 3. PEN-FAST is a prospectively derived and internationally validated clinical decision rule that enables point-of-care risk assessment for adults reporting penicillin allergies.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Patients were randomly assigned to either direct oral challenge with penicillin (intervention arm) or a standard-of-care arm of penicillin skin testing followed by oral challenge with penicillin (control arm).<\/jats:p>\n <\/jats:sec>\n \n Main Outcome and Measure<\/jats:title>\n The primary outcome was a physician-verified positive immune-mediated oral penicillin challenge within 1 hour postintervention in the intention-to-treat population. Noninferiority was achieved if a 1-sided 95% CI of the risk difference (RD) did not exceed 5 percentage points (pp).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 382 adults were randomized, with 377 patients (median [IQR] age, 51 [35-65] years; 247 [65.5%] female) included in the analysis: 187 in the intervention group and 190 in the control group. Most patients had a PEN-FAST score of 0 or 1. The primary outcome occurred in 1 patient (0.5%) in the intervention group and 1 patient (0.5%) in the control group, with an RD of 0.0084 pp (90% CI, \u22121.22 to 1.24 pp). The 1-sided 95% CI was below the noninferiority margin of 5 pp. In the 5 days following the oral penicillin challenge, 9 immune-mediated adverse events were recorded in the intervention group and 10 in the control group (RD, \u22120.45 pp; 95% CI, \u22124.87 to 3.96 pp). No serious adverse events occurred.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this randomized clinical trial, direct oral penicillin challenge in patients with a low-risk penicillin allergy was noninferior compared with standard-of-care skin testing followed by oral challenge. In patients with a low-risk history, direct oral penicillin challenge is a safe procedure to facilitate the removal of a penicillin allergy label.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT04454229<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamainternmed.2023.2986","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T11:33:37Z","timestamp":1689593617000},"page":"944","source":"Crossref","is-referenced-by-count":214,"title":["Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy"],"prefix":"10.1001","volume":"183","author":[{"given":"Ana Maria","family":"Copaescu","sequence":"first","affiliation":[{"name":"Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia"},{"name":"Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada"},{"name":"The Research Institute of the McGill University Health Centre, McGill University Health Centre, McGill University, Montreal, Quebec, Canada"},{"name":"Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Vogrin","sequence":"additional","affiliation":[{"name":"Department of Medicine, St Vincent\u2019s Hospital, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"James","sequence":"additional","affiliation":[{"name":"Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyra Y. L.","family":"Chua","sequence":"additional","affiliation":[{"name":"Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan T.","family":"Rose","sequence":"additional","affiliation":[{"name":"Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia"},{"name":"Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Victoria, Australia"},{"name":"The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"De Luca","sequence":"additional","affiliation":[{"name":"Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia"},{"name":"Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Waldron","sequence":"additional","affiliation":[{"name":"Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Awad","sequence":"additional","affiliation":[{"name":"Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Godsell","sequence":"additional","affiliation":[{"name":"Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia"},{"name":"Department of Clinical Immunology and Allergy, The Royal Melbourne Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Mitri","sequence":"additional","affiliation":[{"name":"Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Lambros","sequence":"additional","affiliation":[{"name":"The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"},{"name":"Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Douglas","sequence":"additional","affiliation":[{"name":"Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia"},{"name":"The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"},{"name":"Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabea","family":"Youcef Khoudja","sequence":"additional","affiliation":[{"name":"The Research Institute of the McGill University Health Centre, McGill University Health Centre, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghislaine A. C.","family":"Isabwe","sequence":"additional","affiliation":[{"name":"Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada"},{"name":"The Research Institute of the McGill University Health Centre, McGill University Health Centre, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Genest","sequence":"additional","affiliation":[{"name":"Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada"},{"name":"The Research Institute of the McGill University Health Centre, McGill University Health Centre, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fein","sequence":"additional","affiliation":[{"name":"Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristine","family":"Radojicic","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Collier","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Lugar","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosby","family":"Stone","sequence":"additional","affiliation":[{"name":"Center for Drug Safety and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Ben-Shoshan","sequence":"additional","affiliation":[{"name":"The Research Institute of the McGill University Health Centre, McGill University Health Centre, McGill University, Montreal, Quebec, Canada"},{"name":"Division of Allergy, Immunology and Dermatology, Montreal Children\u2019s Hospital, McGill University Health Centre McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Turner","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha E.","family":"Holmes","sequence":"additional","affiliation":[{"name":"Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia"},{"name":"Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Phillips","sequence":"additional","affiliation":[{"name":"Center for Drug Safety and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee"},{"name":"Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Trubiano","sequence":"additional","affiliation":[{"name":"Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia"},{"name":"Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"},{"name":"Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"ioi230043r1","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1093\/jac\/dkw008","article-title":"Antimicrobial allergy \u2018labels\u2019 drive inappropriate antimicrobial prescribing: lessons for stewardship.","volume":"71","author":"Trubiano","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"ioi230043r2","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/cid\/ciw462","article-title":"Impact of reported beta-lactam allergy on inpatient outcomes: a multicenter prospective cohort study.","volume":"63","author":"MacFadden","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"7","key":"ioi230043r3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5694\/mja2.2016.204.issue-7","article-title":"Old but not forgotten: antibiotic allergies in general medicine (the AGM study).","volume":"204","author":"Trubiano","year":"2016","journal-title":"Med J Aust"},{"key":"ioi230043r4","doi-asserted-by":"publisher","first-page":"k2400","DOI":"10.1136\/bmj.k2400","article-title":"Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study.","volume":"361","author":"Blumenthal","year":"2018","journal-title":"BMJ"},{"issue":"3","key":"ioi230043r5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/bcp.v85.3","article-title":"Antibiotic allergy labels in hospitalized and critically ill adults: a review of current impacts of inaccurate labelling.","volume":"85","author":"Moran","year":"2019","journal-title":"Br J Clin Pharmacol"},{"issue":"10167","key":"ioi230043r6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(18)32218-9","article-title":"Antibiotic allergy.","volume":"393","author":"Blumenthal","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"ioi230043r8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/QCO.0000000000000006","article-title":"Antimicrobial stewardship\u2019s new weapon? a review of antibiotic allergy and pathways to \u2018de-labeling\u2019.","volume":"26","author":"Trubiano","year":"2013","journal-title":"Curr Opin Infect Dis"},{"issue":"11","key":"ioi230043r9","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/14787210.2020.1792775","article-title":"The democratization of de-labeling: a review of direct oral challenge in adults with low-risk penicillin allergy.","volume":"18","author":"Rose","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"6","key":"ioi230043r10","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update.","volume":"150","author":"Khan","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"ioi230043r11","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.jaip.2019.05.037","article-title":"Comparing direct challenge to penicillin skin testing for the outpatient evaluation of penicillin allergy: a randomized controlled trial.","volume":"7","author":"Mustafa","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"ioi230043r12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/cid\/ciaa653","article-title":"The penicillin allergy delabeling program: a multicenter whole-of-hospital health services intervention and comparative effectiveness study.","volume":"73","author":"Chua","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"5","key":"ioi230043r13","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamainternmed.2020.0403","article-title":"Development and validation of a penicillin allergy clinical decision rule.","volume":"180","author":"Trubiano","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"1","key":"ioi230043r14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.anai.2021.07.005","article-title":"Predictive factors of amoxicillin immediate hypersensitivity and validation of PEN-FAST clinical decision rule.","volume":"128","author":"Piotin","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"8","key":"ioi230043r15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-063784","article-title":"Use of a penicillin allergy clinical decision rule to enable direct oral penicillin provocation: an international multicentre randomised control trial in an adult population (PALACE): study protocol.","volume":"12","author":"Copaescu","year":"2022","journal-title":"BMJ Open"},{"issue":"4","key":"ioi230043r16","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/j.0006-341X.1999.01202.x","article-title":"Test-based exact confidence intervals for the difference of two binomial proportions.","volume":"55","author":"Chan","year":"1999","journal-title":"Biometrics"},{"issue":"5","key":"ioi230043r17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"7","key":"ioi230043r18","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/j.jaip.2022.03.025","article-title":"Safety of direct oral challenge to amoxicillin in pregnant patients at a Canadian tertiary hospital.","volume":"10","author":"Mak","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"24","key":"ioi230043r19","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1056\/NEJMra1807761","article-title":"Penicillin allergy.","volume":"381","author":"Castells","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"ioi230043r20","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw153","article-title":"Improving antimicrobial stewardship by antibiotic allergy delabeling: evaluation of knowledge, attitude, and practices throughout the Emerging Infections Network.","volume":"3","author":"Trubiano","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"ioi230043r21","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlad015","article-title":"Low self-reported penicillin allergy in South Africa\u2014implications for global public health response.","volume":"5","author":"Day","year":"2023","journal-title":"JAC Antimicrob Resist"},{"issue":"10","key":"ioi230043r23","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ioi230043r7","unstructured":"Antimicrobial stewardship interventions: a practice guide. World Health Organization. 2021. Accessed June 10, 2023. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/340709\/9789289054980-eng.pdf"},{"key":"ioi230043r22","unstructured":"Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: a WHO practical toolkit. World Health Organization. 2019. Accessed June 10, 2023. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/329404\/9789241515481-eng.pdf"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2806976\/jamainternal_copaescu_2023_oi_230043_1693517098.10841.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T11:33:02Z","timestamp":1693913582000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2806976"}},"subtitle":["The PALACE Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2023.2986","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}